GlobeNewswire Inc.··DelveinsightPharma's Sepsis Push: 25+ Companies Racing to Fill Critical Treatment Gap
Over 25 pharmaceutical companies are developing 30+ sepsis drugs across clinical stages, with 7+ in late-stage development, addressing a high-mortality therapeutic area with significant unmet needs.
NVSAZNBAYRYclinical trialsbiomarkers